Plasmodium berghei ANKA induces a fatal neurological syndrome known as cerebral malaria (CM) in susceptible mice. Host genetic elements are among the key factors determining susceptibility or resistance to CM. Analysis of mice of the same H-2 haplotype revealed that mouse mammary tumor virus 7 (MTV-7) integration into chromosome 1 is one of the key factors associated with resistance to neurological disease during P. berghei ANKA infection. We investigated this phenomenon by infecting a series of recombinant inbred mice (CXD2), derived from BALB/c (susceptible to CM) and DBA/2 (resistant to CM) mice, with P. berghei ANKA. We observed differences in susceptibility to CM induced by this Plasmodium strain. Mice with the MTV-7 sequence in their genome were resistant to CM, whereas those without integration of this gene were susceptible. Thus, an integrated proviral open reading frame or similar genomic sequences may confer protection against neuropathogenesis during malaria, at least in mice.
Cerebral malaria (CM) is a neurological syndrome caused by the asexual blood stage of Plasmodium falciparum in humans and Plasmodium berghei ANKA in experimental rodent models. Numerous parameters, such as the diversity of parasite populations and genetic polymorphisms in the vertebrate host, influence host-parasite interactions and pathogenesis during malaria infection (6, 22, 27, 29) . It is important to increase our understanding of the mechanisms by which these factors contribute to the development of neuropathogenesis because CM continues to kill 2 to 2.5 million people annually, mostly children in areas where the parasite is endemic (2) .
Several studies with humans have shown that host immunogenetic factors have a significant effect on susceptibility to severe forms of malaria (13, 20, 23) . Genes encoding certain alleles of HLA molecules are known to be associated with protection against pathogenesis during malaria (14, 15) . Alleles of the tumor necrosis factor alpha (TNF-␣) gene have also been shown to be associated with protection against severe malaria (21) . TNF-␣ plays a role in CM development by inducing the expression of adhesion molecules on the surface of endothelial cells of brain microvessels, leading to the sequestration of parasitized erythrocytes due to their cytoadhesion within the vascular system of the brain (7) .
In experimental models, mice lacking interferon (IFN) regulatory factor-1 (IRF-1) have been found to be protected against death due to CM (24) . IRF-1 has been associated with malarial neuropathogenesis via the high level of production of type-1 cell-derived cytokines such as TNF-␣ and IFN-␥ (8-12).
Moreover, inbred mice with the same H-2 haplotype show various degrees of susceptibility to CM and can be divided into three categories: highly susceptible, such as B10.D2 mice; weakly susceptible, such as BALB/c mice; and resistant, such as DBA/2 mice. This suggests that H-2 locus does not play a predominant role in determining susceptibility or resistance to neuropathogenesis during malaria in the mouse model (4) .
Attempts to estimate the relationship between the immune response and disease severity have shown that ␣␤T cells play a direct role in the complex pathogenesis of malaria (4) . In a previous study, we demonstrated that the development of neurological syndromes in B10.D2 mice infected with P. berghei ANKA was associated with an increase in the number of CD8V␤8.1 ϩ and CD8V␤8.2 ϩ T cells in peripheral blood. Strong evidence for a causal link between the expansion of populations of T cells bearing V␤8.1 and/or V␤8.2 and the pathological consequences of P. berghei ANKA infection has been provided by the significantly lower levels of CM observed in mice treated with a monoclonal antibody eliminating all populations of cells bearing T-cell-receptor (TCR) V␤8.1 and V␤8.2 chains. In addition, BALB.D2 mice, which are congenic for a mouse mammary tumor virus (MTV-7) that constitutively depletes V␤6, V␤7, V␤8.1, and V␤9 populations, is susceptible to P. berghei ANKA infection but does not develop CM (4) .
The open reading frame in the 3Ј long terminal repeat of the MTV-7 provirus, which is integrated into chromosome 1 in several mouse strains, encodes a superantigen, Mls1 a . Like all superantigens, Mls1 a elicits a very powerful response from mature T cells bearing the appropriate TCR V␤ chains, and during T-cell maturation in the thymus, this response results in clonal elimination or clonal inactivation of the responding cells (3, 28) . Superantigens may therefore have significant deleterious effects on the T-cell repertoire in the periphery (19) .
These observations indicate that there is an association between the presence of certain TCR-restricted lymphocyte subpopulations and the development of neuropathogenesis in experimental models of malaria. In the present study, we identified a specific example of such an association based on the observation that BALB/c mice (MTV-7 Ϫ ) are susceptible to CM induced by P. berghei ANKA clone 1.49L, whereas BALB.D2 and DBA/2 mice (MTV-7 ϩ ) are resistant. We analyzed the susceptibility and/or resistance to CM of various recombinant inbred (RI) lines of the CXD2 series derived from BALB/c ϫ DBA/2 crosses to investigate the possible role of MTV-7 integration in determining susceptibility or resistance to CM.
MATERIALS AND METHODS
Mice. We used 6-to 8-week-old male and female mice of various CXD2 RI (n Ͼ 20) lines: (CXD2) D (n ϭ 32), (CXD2) E (n ϭ 30), (CXD2) F (n ϭ 23), (CXD2) J (n ϭ 10), (CXD2) K (n ϭ 25), (CXD2) L (n ϭ 26), and (CXD2) N (n ϭ 22). These lines were developed and maintained at the Pasteur Institute (5). Eight-week-old BALB/c J Rj and DBA/2 mice were obtained from Janvier (Le Genest St. Isle, France) and Charles River (Les Elboeuf, France), respectively.
Parasites and induction of cerebral malaria. Erythrocytic stages of clone 1.49L of P. berghei ANKA strain, kindly provided by D. Walliker (Institute of Genetics, Edinburgh, United Kingdom), were maintained in C57BL/6 mice. This clone was selected for its great capacity to induce CM, with neurological signs (ataxia, paralysis, deviation of the head, and convulsion) appearing 6 to 8 days after infection (1) . Blood stages of the clone were used as stabilates (10 7 parasitized red blood cells [pRBC]/ml in Alsever's solution supplemented with 10% glycerol) stored in liquid nitrogen. CM was induced by the intraperitoneal injection of 10 6 PbA-infected RBCs (pRBCs). Parasitemia was monitored by evaluating daily blood smears for parasites after Giemsa staining.
Southern blotting. Genomic DNA samples were isolated from the tail (25), and Southern blot analysis was carried out as previously described (16 Lymphocyte preparation and staining. Peripheral blood lymphocytes (PBL) were isolated from uninfected control mice by centrifugation in Ficoll-Hypaque (Pharmacia) and washed twice with 3% fetal calf serum (Gibco-BRL) in phosphate-buffered saline. For cytofluorometry, lymphocytes were incubated first with biotinylated monoclonal antibody directed against the various V␤s and subsequently with anti-CD3 fluorescein-labeled monoclonal antibody in the presence of phycoerythrin-conjugated streptavidin. Analysis was carried out with a FACScan cytofluorometer (Becton Dickinson, Grenoble, France) and CellQuest software. Viable lymphocytes were gated on the basis of light scattering (FSC/ SSC) and for all V␤ analyses (5,000 to 10,000 events were acquired and recorded per sample). The percentage of fluorescent cells was determined by integrating profiles according to the number of viable lymphocytes.
Statistical analysis. Statistical analysis was carried out with StatView version 4.5 software. Kaplan-Meier tests were used to assess survival. Differences between the survival curves of MTV-7 ϩ and MTV-7 Ϫ mice were analyzed by the Logrank (Mantel-Cox) test. P values of Ͻ0.05 were considered to be significant. Parasitemia is expressed as the mean percentage of all erythrocytes that were infected.
RESULTS AND DISCUSSION
Malaria induced by P. berghei ANKA in susceptible mice typically presents neurological signs (ataxia, paralysis, deviation of the head, and convulsions), which appear 6 to 13 days after infection. In a previous study, we showed that mice of the same major histocompatibility complex haplotype (H-2 d )-B10.D2, BALB/c, and DBA/2-displayed different phenotypes FIG. 1. Profiles of MTV integration in the various (CXD2) RI strains. Genomic DNA was digested with EcoRI, subjected to electrophoresis in a 0.7% agarose gel, and Southern blotted. The membrane was then probed with envelope (A) or long terminal repeat (B) probes. Lambda HindIII DNA was used as a molecular mass marker. 
a MTV integration was determined by Southern blot analysis in the various RI mice strains derived from BALB/c and DBA/2 mice.
in terms of susceptibility to neuropathogenesis induced by intraperitoneal infection with 10 6 P. berghei ANKA-parasitized erythrocytes. All of the B10.D2 mice and 40% of the BALB/c mice were susceptible to CM, whereas DBA/2 mice presented a resistant phenotype (4) . We also demonstrated that the immunopathogenesis of CM in susceptible H-2 d mice was associated with the expansion before death of a restricted T-cell subpopulation bearing V␤8.1 or V␤8.2 receptor chains. Strong evidence supporting the existence of a link between the increase in number of T cells bearing the V␤8.1 or V␤8.2 segment and the pathological consequences of P. berghei ANKA infection was provided by the observation that the incidence of CM was significantly lower in BALB.D2 mice congenic for MTV-7, resulting in the depletion of V␤8.1 ϩ T cells through the open reading frame superantigen and in the (BALB.D2 ϫ B10.D2)F 1 mice (4). We investigated whether MTV-7 was sufficient to induce resistance to CM by using (CXD2) RI strains derived from BALB/c mice bearing MTV-6, -8, and -9 (susceptible to CM) and DBA/2 mice bearing MTV-1, -6, -7, -8, -11, -13, -14, and -17 (resistant to CM). We determined the MTV integration profile in the various (CXD2) RI strains by Southern blotting (Fig. 1) . Of the seven strains analyzed, only the (CXD2) E and F strains had not inherited the MTV-7 locus ( Table 1 ). The Mtv-7 gene encodes a superantigen known to deplete all T-cell subpopulations bearing TCR V␤6, V␤7, V␤8.1, and V␤9 (26) . We therefore assessed the ability of MTV-7 to act as a superantigen by analyzing the TCR V␤ repertoire of PBL by flow cytometry to detect the clonal depletion of cells bearing the reactive TCR V␤s. We observed a loss of TCR V␤6-, V␤7-, V␤8.1-, and V␤9-bearing T cells among the PBL of the (CXD2) D, J, K, L, and N mouse strains, all of which are MTV-7
ϩ . In contrast, we observed no depletion in (CXD2) E and F mice, which are MTV-7 Ϫ (Fig. 2) . We also analyzed neuropathogenesis in the various (CXD2) RI strains after intraperitoneal inoculation with 10 6 P. berghei ANKA-infected erythrocytes. Only (CXD2) E and F mice remained as susceptible to CM as their relative BALB/c parents, whereas (CXD2) D, N, J, K, and L mice displayed a resistant phenotype similar to that of DBA/2 mice (Fig. 3) . All of the mice that developed CM died 7 to 13 days after parasite inoculation; these mice displayed 10 to 15% parasitemia and severe neurological symptoms associated with CM, including hemiplegia and coma. The resistance to neuropathogenesis of MTV-7 ϩ CXD2 mice does not seem to be directly due to resistance to infection by the parasite, since we observed no significant difference in susceptibility, as shown by the parasitemia curves of the CXD2 strains during the first 2 weeks of infection (Fig. 4) . We also observed no correlation between the level of parasitemia and neuropathogenesis. The mice that escaped CM died 20 days later from anemia due to hyperparasitemia.
We compared the incidence of CM in MTV-7 ϩ and MTV-7 Ϫ mice (Fig. 5) . A strong correlation was observed between the presence of Mtv-7 in the mouse genome and protection against neuropathogenesis in experimental malaria infection. A significantly larger percentage of MTV-7 Ϫ mice (58.5%) than of MTV-7 ϩ mice (2.6%) developed CM ( 2 ϭ 59.4, 1 df, and P Ͻ 0.001). We observed no differences in the timing of clinical signs and death of mice that developed CM, regardless of whether they were MTV-7 ϩ or MTV-7 Ϫ (data not shown). Again, the difference in susceptibility to CM cannot be related to parasite growth because no difference in parasitemia was observed between MTV-7 ϩ and MTV-7 Ϫ mice during the first 2 weeks after infection, as confirmed by the Mantel-Cox log rank test ( 2 ϭ 12.47, 1 df, and P ϭ 0.0004; Fig. 6 ). These data suggest that the viral genome product has no direct effect on parasite development and confirm our previous results obtained with BALB.D2 and BALB.SW, which display integration of the endogenous viral genome (Mtv-7) and of its exogenous counterpart MMTV-SW, which encodes the same superantigen, respectively (4). We observed a difference in the sensitivities to CM of RI strains belonging to the MTV-7 Ϫ group. We found that 76% of (CXD2) E mice presented with CM versus only 26% of the (CXD2) F mice. We investigated the possible direct or indirect involvement of MTVs other than MTV-7 in the mechanisms underlying susceptibility or resistance to neuropathogenesis during P. berghei ANKA infection. We compared the MTV integration profiles of (CXD2) E and (CXD2) F mice with each other and with those of all of the other CXD2 mice studied. The only difference found between these two strains was that MTV-11 was absent from (CXD2) E (Table 1) . This observation raised questions about possible interaction between mechanisms induced by MTV-7 and by MTV-11, conferring resistance to neurological disease in (CXD2) F mice. The log rank test showed a significant difference in CM incidence between MTV-11 ϩ and MTV-11 Ϫ mice for the MTV-7 ϩ (CXD2) E and F mouse lines ( 2 ϭ 7.79, 1 df, and P ϭ 0.0053). However, MTV-11 itself had no direct effect on the incidence of CM. MTV-7 probably plays a complex role in determining susceptibility to Plasmodium infection, depending on the parasite species and the strain of mouse and probably also the developmental stage at which the mice were experimentally infected. Our results show that MTV-7 does not affect susceptibility to P. berghei ANKA infection.
In agreement with results presented here and our results demonstrating that the development of CM in H-2 d haplotype (B10.D2) mice is correlated with an increase of PBL bearing V␤8.1 TCR before death and that all mouse strains lacking V␤8.1 ϩ T cells due to antibody depletion or deletion and anergy resulting from superantigen activity are resistant to CM (4), we therefore conclude that MTV-7, whether provided endogenously or exogenously, is sufficient to confer resistance to CM in laboratory mice strains with the H- how V␤8 ϩ cells affect neuropathogenesis. These cells may release IFN-␥ and TNF, two major mediators of malaria pathogenesis, by inducing the expression of adhesion molecules on the endothelial cells of brain capillaries responsible for the sequestration of infected erythrocytes, leukocytes, and monocytes (27) .
MTV has also been shown to protect against pathogenesis in Leishmania major infection. The mice of most inbred strains are resistant to infection by L. major, whereas the BALB/c strain is unable to control the infection and develops progressive disease. In this experimental model, V␤4V␣8 TCR ϩ CD4 T cells have been demonstrated to be responsible for the early burst of interleukin-4 involved in the Th2 response that confers susceptibility to disease (17) . Moreover, it has been shown that BALB/c mice infected with MMTV-SIM, resulting in the depletion of cells expressing V␤4 TCR, become specifically resistant to infection by L. major, whereas BALB/c mice infected with MMTV-SW, resulting in the depletion of V␤6 ϩ T cells, do not become resistant.
In conclusion, this study, as well as previously published data (4), provides a defined genetic and cellular basis for susceptibility and resistance in experimental murine CM involving modification of the T-cell repertoire by depletion of a precise T-cell subset. Future studies should seek to determine the underlying mechanism and, perhaps most important of all, whether similar mechanisms operate in P. falciparum infection in humans. 
